Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Additional mailing phase for FIT after a medical offer phase: The best way to improve compliance with colorectal cancer screening in France |
Type de publication | Journal Article |
Year of Publication | 2017 |
Auteurs | Piette C, Durand G, Bretagne J-F, Faivre J |
Journal | DIGESTIVE AND LIVER DISEASE |
Volume | 49 |
Pagination | 308-311 |
Date Published | MAR |
Type of Article | Article |
ISSN | 1590-8658 |
Mots-clés | Colorectal cancer, compliance, Immunochemical test, Screening |
Résumé | Background: Compliance with colorectal cancer screening is critical to its effectiveness. The organisation of the mass screening programme in France has recently been modified with no evaluation of the consequences. Aims: To evaluate the impact of the way the screening test is delivered on compliance. Patients and methods: During the first six months of the screening campaign (Ille-Vilaine, Brittany), general practitioners were asked to propose a faecal immunochemical test (FIT), OC-Sensor, to individuals at average risk for colorectal cancer (n = 152,097). A subset of non-participants in the medical phase (n = 13,071) was randomly chosen to receive a reminder that included the screening test or a simple postal reminder without the screening test. Results: Compliance was 31% if the screening test was proposed during a medical consultation. In nonparticipants during the medical phase, it was 45% in those receiving both a reminder and the screening test and 28% amongst those receiving a simple reminder. An estimated overall participation rate of 54% can be expected if non-participants in the medical phase are sent a reminder together with the screening test. Conclusion: In France, a compliance rate above the minimum uptake rate of 45% recommended by European Union experts can be achieved if the FIT is mailed to non-participants after the medical free-offer phase. (c) 2016 Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l. |
DOI | 10.1016/j.dld.2016.09.015 |